Arginine deiminase derived from mycoplasma arthritidis and polymer
conjugates containing the same
    1.
    发明授权
    Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same 有权
    衍生自关节炎支原体的精氨酸脱亚胺酶和含有它的聚合物共轭物

    公开(公告)号:US6132713A

    公开(公告)日:2000-10-17

    申请号:US271713

    申请日:1999-03-18

    摘要: A purified arginine deiminase (ADI) obtained from Mycoplasma arthritidis having the amino acid sequence of SEQ ID NO:2 as well as an isolated nucleic acid molecule containing a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NO:1 are disclosed. Other aspects of the invention include an expression vector, a cloned gene for expressing the Mycoplasma arthritidis derived ADI, (recombinant) host cells useful in expressing the ADI of the present invention and substantially non-antigenic polymer conjugates containing the ADI of the present invention as well as methods of treating arginine deiminase susceptible conditions in mammals. The arginine deiminase-polymer conjugates have high levels of retained enzyme activity and relatively long circulating lives.

    摘要翻译: 公开了从具有SEQ ID NO:2的氨基酸序列的关节炎支原体获得的纯化精氨酸脱亚氨酶(ADI)以及含有编码SEQ ID NO:1所示的氨基酸序列的核苷酸序列的分离的核酸分子。 本发明的其它方面包括表达载体,用于表达来源于关节炎支原体的ADI的克隆基因,用于表达本发明的ADI的重组宿主细胞和含有本发明的ADI的基本上非抗原性的聚合物缀合物,作为 以及在哺乳动物中治疗精氨酸脱亚胺酶易感条件的方法。 精氨酸脱亚氨酶 - 聚合物共轭物具有高水平的保留酶活性和较长的循环寿命。